167843-57-4

Basic information

• Product Name: TERT-BUTYL (4-AMINOPHENOXY)ACETATE
• Synonyms: TERT-BUTYL (4-AMINOPHENOXY)ACETATE
• CAS NO: 167843-57-4
• Molecular Formula: C₁₂H₁₇NO₃
• Molecular Weight: 223.27
• Mol File: 167843-57-4.mol
• Article Data: 13

Chemical Properties

• Appearance: /
• CAS DataBase Reference: TERT-BUTYL (4-AMINOPHENOXY)ACETATE(CAS DataBase Reference)
• NIST Chemistry Reference: TERT-BUTYL (4-AMINOPHENOXY)ACETATE(167843-57-4)
• EPA Substance Registry System: TERT-BUTYL (4-AMINOPHENOXY)ACETATE(167843-57-4)

Safety Data

• Hazardous Substances Data: 167843-57-4(Hazardous Substances Data)

Usage

General Description

TERT-BUTYL (4-AMINOPHENOXY)ACETATE is a chemical compound that belongs to the family of tert-butyl amines and is used in various industrial applications as a intermediate for pharmaceuticals, pesticides, and synthetic materials. It is a tert-butyl derivative of 4-aminophenoxyacetic acid and is commonly used as a building block in organic synthesis due to its stability, reactivity, and solubility properties. TERT-BUTYL (4-AMINOPHENOXY)ACETATE is known for its potential as a versatile starting material for the production of pharmaceutical drugs and agrochemicals, as well as in the formulation of specialty chemicals for various industrial processes.

Upstream product

• 100-02-7 4-nitro-phenol 
• 5292-43-3 bromoacetic acid tert-butyl ester 
• 1798-11-4 4-nitrophenoxyacetic acid 
• 20768-14-3 (4-nitrophenoxy)acetic acid tert-butyl ester 

Downstream Products

• 174774-81-3 t-butyl 4-[(6-cyanobenzo[b]thien-2-yl)carbonylamino]phenoxyacetate 
• 174774-57-3 tert-butyl 4-(methylamino)phenoxyacetate 
• 174774-78-8 t-butyl 4-[(6-cyano-2-indolyl)carbonylamino]phenoxyacetate 
• 174774-79-9 t-butyl 4-[(6-cyano-1-methyl-2-indolyl)carbonylamino]phenoxyacetate 
• 174774-56-2 t-butyl 4-[(5-cyano-3-methyl-2-benzofuranyl)carbonylamino]-phenoxyacetate 
• 174774-80-2 t-butyl 4-[(5-cyanobenzo [b]thien-2-yl)carbonylamino]phenoxyacetate 
• 174775-40-7 t-Butyl 4-(5-cyanofuro[2,3-b]pyridine-2-carbonylamino)phenoxy-acetate 
• 174774-54-0 tert-butyl 4-(5-cyanobenzofuran-2-carboxamido)phenoxyacetate 
• 174774-58-4 tert-butyl (4-succinimidomethylamino)phenoxyacetate 
• 207445-09-8 [4-((R)-2-Benzyloxycarbonylamino-3-phenyl-propionylamino)-phenoxy]-acetic acid tert-butyl ester 
• 1202164-04-2 tert-butyl 2-(4-(((2-methoxy-6-phenylpyridin-3-yl)methyl)amino)-phenoxy)ethanoate 
• 207445-12-3 {(S)-2-[(R)-1-(4-tert-Butoxycarbonylmethoxy-phenylcarbamoyl)-2-phenyl-ethylcarbamoyl]-pyrrolidin-1-yl}-oxo-acetic acid methyl ester 

Relevant articles and documents

Conversion of the LXR-agonist TO-901317-From inverse to normal modulation of γ-secretase by addition of a carboxylic acid and a lipophilic anchor

TO-901317, a LXR agonist, is an inverse modulator of Alzheimer's disease associated γ-secretase. We synthesized TO-901317 analogous compound but replaced the hexafluorocarbinol moiety by an oxyacetic acid functionality and hypothesized that the replacemen

QUINOLINE DERIVATIVES USEFUL AS CB-1 INVERSE AGONISTS

The present invention is directed to quinoline derivatives, pharmaceutical compositions containing said derivatives and their use in the treatment of disorders and conditions mediated by the CB-1 receptor; more particularly, in the treatment of disorders

PPAR AGONIST COMPOUNDS, PREPARATION AND USES

The present invention relates to novel PPAR agonist compounds as well as pharmaceutical compositions containing them. The compounds according to the invention are of quite particular therapeutic interest, notably for treating diabetes and/or dyslipidemias, as well as for preventing cardiovascular pathologies.